Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3504553 | 0.88 | — | — | |
| SCHEMBL1810381 | 0.85 | NR1H2 (0.33) | RIPK1DPP4 | |
| SCHEMBL18322450 | 0.85 | RIPK1 (0.34) | RIPK1DPP4 | |
| SCHEMBL3586527 | 0.84 | RIPK1 (0.31) | RIPK1DPP4 | |
| SCHEMBL482006 | 0.84 | NCF1 (0.36) | RIPK1DPP4 | |
| SCHEMBL15864996 | 0.84 | SMYD3 (0.30) | — | |
| SCHEMBL619575 | 0.83 | TYMP (0.33) | RIPK1DPP4 | |
| SCHEMBL28366570 | 0.82 | NR1H2 (0.38) | — | |
| SCHEMBL7990391 | 0.81 | PREP (0.31) | — | |
| SCHEMBL2525440 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105705488-B | Compounds of acetylcholinesterase inhibitors and 5-hydroxytryptamine receptor 4 agonists, process for their preparation and pharmaceutical compositions thereof | 卡昂大学 | 2020-03-24 | — | — | CN | disclosed |
| US-20110098296-A1 | Thiazole And Oxazole Kinase Inhibitors | GLAXOSMITHKLINE LLC | 2011-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098296-A1 | Thiazole And Oxazole Kinase Inhibitors | PDXK, MAP3K1, MAP4K2 | RIPK1 461/4885DPP4 513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.